Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00510016
Status:
COMPLETED
Last Update Posted:
2017-01-11
First Post:
2007-07-31
Brief Title:
Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
Efficacy of Clonidine in the Treatment of Neonatal Abstinence Syndrome A Prospective Double Blind Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2007-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NAS
Brief Summary:
To test the hypothesis that the combination of the tincture of opium DTO and clonidine will be more effective in treating infants with neonatal abstinence syndrome opioid withdrawal than tincture of opium DTO alone
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 1R21DA016288-01A1 | NIH | None | httpsreporternihgovquickSearch1R21DA016288-01A1 |